PDL BioPharma Inc(PDLI)
2.47
Change: -0.07 (▼ -2.72%)
As of Thu 12/15/2022 12:55 PM% Of Value
Growth
Value Per Share
:
:
:
222.52
-72.36
-2.4700 (as of 30/12/2020)
NO DATA TO DISPLAY
Fundamentals Data
| Open | 2.73 | Dividend | 164 |
| Close Price | 2.47 | DivYield | 6.41 % |
| High | 2.78 | Growth | -143.3 M |
| Low | 2.39 | Growth% | -72.36 |
| P/e | -6.605 | Volume | 30.2 M |
| P/b | 1.41 | Market Capital | 316.4 M |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 50 Days Moving Average Percentage | 2.0607287449393 (as of 17/10/2021 |
| Industry: Biotechnology: Biological Products (No Diagnostic Substances) |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2014 | Year2 / 2016 | Year3 / 2017 | Year4 / 2018 | Current Year / 2019 |
| Revenue | 0.0 | 0.0 | 320.0 M | 198.1 M | 54.7 M |
| Cap Spending | 0.0 | 0.0 | 105.9 M | 53.4 M | 76.8 M |
| Operating Expenses | 0.0 | 0.0 | 95.7 M | 200.2 M | 100.9 M |
| Operating Cash Flow | 0.0 | 0.0 | 193.7 M | -50.5 M | -99.8 M |
| Free Cash Flow | 0.0 | 0.0 | 146.5 M | 40.0 M | 44.3 M |
| Free Cash Flow Per Share | 0.943 | 0.275 | 0.374 | ||
| Total liabilities | 0.0 | 0.0 | 243.4 M | 124.6 M | 27.2 M |
| Total cash | 0.0 | 0.0 | 527.2 M | 394.5 M | 193.4 M |
| ROE% | 0.136 | -0.091 | -0.109 | ||
| Outstanding Shares | 0.0 | 0.0 | 153.8 M | 128.1 M | 123.5 M |
| P/E | 3.972 | -6.605 | -5.389 | ||
| P/S | 1.374 | 2.296 | 6.929 | ||
| Revenue USD | 0.0 | 0.0 | 320.0 M | 198.1 M | 54.7 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|